Sandra Verelst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandra Verelst has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Greet Van De Sijpe
Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium
3 shared publications - Lorenz Van der Linden
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
3 shared publications - Matthias Gijsen
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
3 shared publications - Sabrina De Winter
Pharmacy Department, University Hospitals Leuven, Leuven, Belgium
3 shared publications - Veerle Foulon
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
3 shared publications - Didier Desruelles
Department of Emergency Medicine, University Hospitals Leuven, 3000 Leuven, Belgium
2 shared publications
Latest Publications
- Open Access
- 27 November 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26 (1) , e55185
A Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study
Background: Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. Objective: The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. Methods: A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. Results: We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. Conclusions: Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.
- 27 November 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26 (1) , e55185
Open AccessA Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study
Background: Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. Objective: The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. Methods: A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. Results: We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. Conclusions: Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.
- Open Access
- 5 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
A Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study (Preprint)
BACKGROUND Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. OBJECTIVE The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. METHODS A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. RESULTS We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. CONCLUSIONS Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.
- 5 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study (Preprint)
BACKGROUND Many patients do not receive a comprehensive medication reconciliation, mostly owing to limited resources. We hence need an approach to identify those patients at the emergency department (ED) who are at increased risk for clinically relevant discrepancies. OBJECTIVE The aim of our study was to develop and externally validate a prediction model to identify patients at risk for at least 1 clinically relevant medication discrepancy upon ED presentation. METHODS A prospective, multicenter, observational study was conducted at the University Hospitals Leuven and General Hospital Sint-Jan Brugge-Oostende AV, Belgium. Medication histories were obtained from patients admitted to the ED between November 2017 and May 2022, and clinically relevant medication discrepancies were identified. Three distinct datasets were created for model development, temporal external validation, and geographic external validation. Multivariable logistic regression with backward stepwise selection was used to select the final model. The presence of at least 1 clinically relevant discrepancy was the dependent variable. The model was evaluated by measuring calibration, discrimination, classification, and net benefit. RESULTS We included 824, 350, and 119 patients in the development, temporal validation, and geographic validation dataset, respectively. The final model contained 8 predictors, for example, age, residence before admission, number of drugs, and number of drugs of certain drug classes based on Anatomical Therapeutic Chemical coding. Temporal validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index (concordance index) of 0.67 (95% CI 0.61-0.73). In the geographic validation dataset, the calibration slope and intercept were 1.35 and 0.83, respectively, and the c-index was 0.68 (95% CI 0.58-0.78). The model showed net benefit over a range of clinically reasonable threshold probabilities and outperformed other selection criteria. CONCLUSIONS Our software-implemented prediction model shows moderate performance, outperforming random or typical selection criteria for medication reconciliation. Depending on available resources, the probability threshold can be customized to increase either the specificity or the sensitivity of the model.
- Open Access
- 1 March 2023
- Published by BMJ
- Vol. 30 (Suppl 1) , A193.1-A193
4CPS-114 Development and prospective validation of a prediction model to identify clinically relevant medication discrepancies at the emergency department
Background and Importance Medication discrepancies occur in a majority of hospital admissions to the emergency department (ED) and are a major source of avoidable harm. Obtaining an accurate medication history is essential to identify drug-related problems early on. However, the medication reconciliation process is prone to many errors and is furthermore labour-intensive. As a result, many patients simply do not receive a complete medication reconciliation, mostly owing to limited recourses. We hence need an approach which enables us to identify those patients at the ED who are at increased risk for clinically relevant discrepancies. Aim and Objectives To develop and prospectively validate a prediction model to identify patients who are at risk for at least one clinically relevant medication discrepancy at the time of ED presentation. Material and Methods A prospective study was carried out at the ED. Medication histories were obtained and clinically relevant discrepancies were identified, using an internally validated scoring tool. Two distinct datasets were created. A first dataset (n=824) was used to build and internally validate a prediction model. We used multivariable logistic regression with backward stepwise selection to select the final model. A second dataset (n= 350) was used to prospectively validate the prediction model. The predictive performance of this model was assessed by measuring calibration, discrimination and classification. Results The final model contained nine predictors that can easily be obtained upon ED admission, including age, origin before admission (home/nursing home) and number of drugs. Prospective validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index of 0.66. Using a probability threshold of 0.4, the sensitivity, specificity, positive predictive value, negative predictive value and alert rate was 41%, 81%, 56%, 70% and 27%, respectively. Conclusion and Relevance The presence of at least one clinically relevant medication discrepancy can be predicted by our model with moderate performance. Using our prediction model is more efficient than performing medication reconciliation at random and can guide the rational use of limited resources at the ED. Depending on the available resources, different probability thresholds can be applied to increase either the specificity or the sensitivity of the prediction model. Conflict of Interest No conflict of interest
- 1 March 2023
- Published by BMJ
- Vol. 30 (Suppl 1) , A193.1-A193
Open Access4CPS-114 Development and prospective validation of a prediction model to identify clinically relevant medication discrepancies at the emergency department
Background and Importance Medication discrepancies occur in a majority of hospital admissions to the emergency department (ED) and are a major source of avoidable harm. Obtaining an accurate medication history is essential to identify drug-related problems early on. However, the medication reconciliation process is prone to many errors and is furthermore labour-intensive. As a result, many patients simply do not receive a complete medication reconciliation, mostly owing to limited recourses. We hence need an approach which enables us to identify those patients at the ED who are at increased risk for clinically relevant discrepancies. Aim and Objectives To develop and prospectively validate a prediction model to identify patients who are at risk for at least one clinically relevant medication discrepancy at the time of ED presentation. Material and Methods A prospective study was carried out at the ED. Medication histories were obtained and clinically relevant discrepancies were identified, using an internally validated scoring tool. Two distinct datasets were created. A first dataset (n=824) was used to build and internally validate a prediction model. We used multivariable logistic regression with backward stepwise selection to select the final model. A second dataset (n= 350) was used to prospectively validate the prediction model. The predictive performance of this model was assessed by measuring calibration, discrimination and classification. Results The final model contained nine predictors that can easily be obtained upon ED admission, including age, origin before admission (home/nursing home) and number of drugs. Prospective validation showed excellent calibration with a slope of 1.09 and an intercept of 0.18. Discrimination was moderate with a c-index of 0.66. Using a probability threshold of 0.4, the sensitivity, specificity, positive predictive value, negative predictive value and alert rate was 41%, 81%, 56%, 70% and 27%, respectively. Conclusion and Relevance The presence of at least one clinically relevant medication discrepancy can be predicted by our model with moderate performance. Using our prediction model is more efficient than performing medication reconciliation at random and can guide the rational use of limited resources at the ED. Depending on the available resources, different probability thresholds can be applied to increase either the specificity or the sensitivity of the prediction model. Conflict of Interest No conflict of interest
- 19 August 2021
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 77 (4) , 742-747
The 12 -year evolution of emergency department alcohol-related admissions in a student city
To investigate the trends in incidence of alcohol-intoxicated patients who present at the emergency department (ED), as well as the characteristics of these patients.Retrospective observational stu...
- 19 August 2021
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 77 (4) , 742-747
The 12 -year evolution of emergency department alcohol-related admissions in a student city
To investigate the trends in incidence of alcohol-intoxicated patients who present at the emergency department (ED), as well as the characteristics of these patients.Retrospective observational stu...
- 1 August 2021
- Published by Elsevier in Resuscitation
- Vol. 165, 140-147
Assessment of chest compression interruptions during advanced cardiac life support
- 1 August 2021
- Published by Elsevier in Resuscitation
- Vol. 165, 140-147
Assessment of chest compression interruptions during advanced cardiac life support
- 1 August 2021
- Published by Elsevier in Resuscitation
- Vol. 165, 1-7
Impact of video-recording on patient outcome and data collection in out-of-hospital cardiac arrests
- 1 August 2021
- Published by Elsevier in Resuscitation
- Vol. 165, 1-7
Impact of video-recording on patient outcome and data collection in out-of-hospital cardiac arrests
- 1 September 2020
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 109, 103657
Predicting patient nurse-level intensity for a subsequent shift in the intensive care unit: A single-centre prospective observational study
- 1 September 2020
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 109, 103657
Predicting patient nurse-level intensity for a subsequent shift in the intensive care unit: A single-centre prospective observational study
- Open Access
- 1 July 2018
- Published by Elsevier in International Emergency Nursing
- Vol. 39, 68-76
Developing an emergency department crowding dashboard: A design science approach
- 1 July 2018
- Published by Elsevier in International Emergency Nursing
- Vol. 39, 68-76
Open AccessDeveloping an emergency department crowding dashboard: A design science approach
- Open Access
- 5 April 2012
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 47 (4) , 433-438
Emergency Department Visits Due to Alcohol Intoxication: Characteristics of Patients and Impact on the Emergency Room
Aims: The aim of the study was to describe the epidemiology, management and cost of emergency department (ED) visits due to alcohol intoxication. Methods: A retrospective review of medical records of all episodes of alcohol intoxication was made, excepting those where another diagnosis such as trauma or psychiatric illness was primary, in patients older than 16 years, who presented to the ED of a large university hospital in Belgium over a 12-month period from 1 January 2009. Results: A total of 635 such patients accounted for 1.2% of all ED visits; 429 were males and 48.3% were aged between 41 and 60 years; 63.8% of the patients had a history of alcohol use disorder and 60.3% had a history of psychiatric disorder; 74.3% of the patients received some form of medical treatment and 62% were seen by a psychiatrist. Of the total, 57.5% of the patients were admitted to the ED observation ward, with a mean length of stay of 8.4 h. The estimated total cost was €318 838.25, with an average of €541.32 per patient. Conclusion: Alcohol intoxication leads to a financial burden on the community. In addition to imposing physical, social and psychological stress on the community, the often agitated or aggressive patient imposes stress on ED staff. Close surveillance of trends in alcohol abuse is warranted, and the ED should consider implementing a questionnaire method of screening for alcohol abuse.
- 5 April 2012
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 47 (4) , 433-438
Open AccessEmergency Department Visits Due to Alcohol Intoxication: Characteristics of Patients and Impact on the Emergency Room
Aims: The aim of the study was to describe the epidemiology, management and cost of emergency department (ED) visits due to alcohol intoxication. Methods: A retrospective review of medical records of all episodes of alcohol intoxication was made, excepting those where another diagnosis such as trauma or psychiatric illness was primary, in patients older than 16 years, who presented to the ED of a large university hospital in Belgium over a 12-month period from 1 January 2009. Results: A total of 635 such patients accounted for 1.2% of all ED visits; 429 were males and 48.3% were aged between 41 and 60 years; 63.8% of the patients had a history of alcohol use disorder and 60.3% had a history of psychiatric disorder; 74.3% of the patients received some form of medical treatment and 62% were seen by a psychiatrist. Of the total, 57.5% of the patients were admitted to the ED observation ward, with a mean length of stay of 8.4 h. The estimated total cost was €318 838.25, with an average of €541.32 per patient. Conclusion: Alcohol intoxication leads to a financial burden on the community. In addition to imposing physical, social and psychological stress on the community, the often agitated or aggressive patient imposes stress on ED staff. Close surveillance of trends in alcohol abuse is warranted, and the ED should consider implementing a questionnaire method of screening for alcohol abuse.
- 1 March 2009
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 47 (3) , 236-238
Ethylene glycol poisoning presenting with a falsely elevated lactate level
Early diagnosis of ethylene glycol poisoning is crucial in order to prevent morbidity and mortality. However, diagnosis can sometimes be delayed because of the false elevation of lactate in some chemistry analyzers as a result of the interference of glycolate, a metabolite of ethylene glycol. We present a case of ethylene glycol poisoning presenting with a falsely elevated lactate level on a blood gas analyzer in the emergency department. Given the fact that nowadays there is a marked increase in use of point-of-care analyzers, one should be aware of possible false readings since they use different methods of measuring compared with clinical chemistry analyzers. On the other hand, measuring a “lactate gap” using two different technologies, only one of which is sensitive to glycolate, could be a clinically efficient way to make the diagnosis of advanced ethylene glycol poisoning in the emergency department or other critical care setting.
- 1 March 2009
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 47 (3) , 236-238
Ethylene glycol poisoning presenting with a falsely elevated lactate level
Early diagnosis of ethylene glycol poisoning is crucial in order to prevent morbidity and mortality. However, diagnosis can sometimes be delayed because of the false elevation of lactate in some chemistry analyzers as a result of the interference of glycolate, a metabolite of ethylene glycol. We present a case of ethylene glycol poisoning presenting with a falsely elevated lactate level on a blood gas analyzer in the emergency department. Given the fact that nowadays there is a marked increase in use of point-of-care analyzers, one should be aware of possible false readings since they use different methods of measuring compared with clinical chemistry analyzers. On the other hand, measuring a “lactate gap” using two different technologies, only one of which is sensitive to glycolate, could be a clinically efficient way to make the diagnosis of advanced ethylene glycol poisoning in the emergency department or other critical care setting.